These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6384328)

  • 1. Amiodarone treatment of critical arrhythmias in children and young adults.
    Garson A; Gillette PC; McVey P; Hesslein PS; Porter CJ; Angell LK; Kaldis LC; Hittner HM
    J Am Coll Cardiol; 1984 Oct; 4(4):749-55. PubMed ID: 6384328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up of amiodarone therapy in the young: continued efficacy, unimpaired growth, moderate side effects.
    Guccione P; Paul T; Garson A
    J Am Coll Cardiol; 1990 Apr; 15(5):1118-24. PubMed ID: 2312967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy.
    Nademanee K; Singh BN; Hendrickson JA; Reed AW; Melmed S; Hershman J
    Circulation; 1982 Jul; 66(1):202-11. PubMed ID: 7083508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of amiodarone for refractory supraventricular tachyarrhythmias.
    Graboys TB; Podrid PJ; Lown B
    Am Heart J; 1983 Oct; 106(4 Pt 2):870-6. PubMed ID: 6613832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias.
    Rowland E; Krikler DM
    Br Heart J; 1980 Jul; 44(1):82-90. PubMed ID: 7426165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of amiodarone in children.
    Coumel P; Lucet V; Do Ngoc D
    Pacing Clin Electrophysiol; 1983 Sep; 6(5 Pt 1):930-9. PubMed ID: 6195613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
    Coumel P; Leclercq JF; Assayag P
    Am J Cardiol; 1984 Nov; 54(9):60D-66D. PubMed ID: 6208770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High incidence of clinical and subclinical toxicity associated with amiodarone treatment of refractory tachyarrhythmias.
    Anastasiou-Nana MI; Anderson JL; Nanas JN; Lutz JR; Smith RA; Anderson KP; Crapo RO; Call NB
    Can J Cardiol; 1986; 2(3):138-45. PubMed ID: 2941121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic effects of amiodarone in patients with refractory ventricular tachycardia.
    Saksena S; Rothbart ST; Cappello G
    Int J Cardiol; 1983 Jun; 3(3):339-52. PubMed ID: 6347914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of amiodarone as an antiarrhythmic agent.
    Rosenbaum MB; Chiale PA; Halpern MS; Nau GJ; Przybylski J; Levi RJ; Lázzari JO; Elizari MV
    Am J Cardiol; 1976 Dec; 38(7):934-44. PubMed ID: 793369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term therapy with amiodarone in tachyarrhythmias--report on various experiences with special reference to its side effects].
    Assmann I
    Z Gesamte Inn Med; 1985 Jun; 40(11):335-41. PubMed ID: 4036210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amiodarone in the treatment of cardiac arrhythmias in children: one hundred thirty-five cases.
    Coumel P; Fidelle J
    Am Heart J; 1980 Dec; 100(6 Pt 2):1063-9. PubMed ID: 7446409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amiodarone for long-term management of patients with hypertrophic cardiomyopathy.
    McKenna WJ; Harris L; Rowland E; Kleinebenne A; Krikler DM; Oakley CM; Goodwin JF
    Am J Cardiol; 1984 Oct; 54(7):802-10. PubMed ID: 6541429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repetitive supraventricular tachycardia: clinical manifestations and response to therapy with amiodarone.
    Haines DE; Lerman BB; DiMarco JP
    Pacing Clin Electrophysiol; 1986 Jan; 9(1 Pt 1):130-3. PubMed ID: 2419843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral propafenone therapy for children with arrhythmias: efficacy and adverse effects in midterm follow-up.
    Guccione P; Drago F; Di Donato RM; Cicini MP; Pasquini L; Marino B; Marcelletti C; Ragonese P
    Am Heart J; 1991 Oct; 122(4 Pt 1):1022-7. PubMed ID: 1927853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intravenous amiodarone in the therapy of paroxysmal supraventricular tachycardias].
    Storelli A; Andriulo C; Chisena A; De Giorgi M; De Giorgio NA; Gallone V; Guadalupi M; Lupis O; Nadovezza S; Tarentini A
    G Ital Cardiol; 1985 Mar; 15(3):290-7. PubMed ID: 4018468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias.
    Greene HL; Graham EL; Werner JA; Sears GK; Gross BW; Gorham JP; Kudenchuk PJ; Trobaugh GB
    J Am Coll Cardiol; 1983 Dec; 2(6):1114-28. PubMed ID: 6685151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amiodarone-induced torsades de pointes.
    Brown MA; Smith WM; Lubbe WF; Norris RM
    Eur Heart J; 1986 Mar; 7(3):234-9. PubMed ID: 3709557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amiodarone: an effective alternative for recalcitrant supraventricular and ventricular tachycardias.
    Best JF; Rinkenberger R; Lynch L; Dunn M
    Clin Cardiol; 1986 Jun; 9(6):268-71. PubMed ID: 2424656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmias.
    Podrid PJ; Lown B
    Am Heart J; 1981 Apr; 101(4):374-9. PubMed ID: 7211665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.